101 related articles for article (PubMed ID: 20658962)
1. Therapeutic targeting of miRNAs in neuroblastoma.
Stallings RL; Foley NH; Bryan K; Buckley PG; Bray I
Expert Opin Ther Targets; 2010 Sep; 14(9):951-62. PubMed ID: 20658962
[TBL] [Abstract][Full Text] [Related]
2. N-myc and noncoding RNAs in neuroblastoma.
Buechner J; Einvik C
Mol Cancer Res; 2012 Oct; 10(10):1243-53. PubMed ID: 22936790
[TBL] [Abstract][Full Text] [Related]
3. Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma.
Bettinsoli P; Ferrari-Toninelli G; Bonini SA; Prandelli C; Memo M
BMC Cancer; 2017 May; 17(1):352. PubMed ID: 28525978
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of neuroblastoma.
George RE; Diller L; Bernstein ML
Expert Opin Pharmacother; 2010 Jun; 11(9):1467-78. PubMed ID: 20408767
[TBL] [Abstract][Full Text] [Related]
5. [The role of MicroRNAs in the pathophysiology of neuroblastoma and their possible use in diagnosis, prognosis and therapy].
Vinklárek J; Novák J; Bienertová-Vašků J; Stěrba J; Slabý O
Klin Onkol; 2014; 27(5):331-9. PubMed ID: 25312710
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and their target gene networks in renal cell carcinoma.
Redova M; Svoboda M; Slaby O
Biochem Biophys Res Commun; 2011 Feb; 405(2):153-6. PubMed ID: 21232526
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-24 inhibits cell migration and invasion in the neuroblastoma cell line SH-SY5Y.
Zhuo B; Wang R; Zhang H; Qin H; Yin Y; Shi Y
Oncol Rep; 2013 Dec; 30(6):2749-54. PubMed ID: 24084981
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in neuroblastoma: small-sized players with a large impact.
Zhi F; Wang R; Wang Q; Xue L; Deng D; Wang S; Yang Y
Neurochem Res; 2014 Apr; 39(4):613-23. PubMed ID: 24477657
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
Welch C; Chen Y; Stallings RL
Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
Metias SM; Lianidou E; Yousef GM
J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
Babashah S; Soleimani M
Eur J Cancer; 2011 May; 47(8):1127-37. PubMed ID: 21402473
[TBL] [Abstract][Full Text] [Related]
14. Insight into the role of microRNAs in brain tumors (review).
Catania A; Maira F; Skarmoutsou E; D'Amico F; Abounader R; Mazzarino MC
Int J Oncol; 2012 Mar; 40(3):605-24. PubMed ID: 22179098
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
Shi M; Liu D; Duan H; Shen B; Guo N
Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
[TBL] [Abstract][Full Text] [Related]
16. Prospects for therapeutic inhibition of neuroblastoma angiogenesis.
Shusterman S; Maris JM
Cancer Lett; 2005 Oct; 228(1-2):171-9. PubMed ID: 15927358
[TBL] [Abstract][Full Text] [Related]
17. miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.
Wang HF; Chen H; Ma MW; Wang JA; Tang TT; Ni LS; Yu JL; Li YZ; Bai BX
Oncol Rep; 2013 Jul; 30(1):520-6. PubMed ID: 23670160
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: promising therapeutic targets for the treatment of pulmonary arterial hypertension.
Yuan K; Orcholski M; Tian X; Liao X; de Jesus Perez VA
Expert Opin Ther Targets; 2013 May; 17(5):557-64. PubMed ID: 23379818
[TBL] [Abstract][Full Text] [Related]
19. microRNAs: Master regulators as potential therapeutics in cancer.
Garofalo M; Croce CM
Annu Rev Pharmacol Toxicol; 2011; 51():25-43. PubMed ID: 20809797
[TBL] [Abstract][Full Text] [Related]
20. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas.
Gestblom C; Grynfeld A; Ora I; Ortoft E; Larsson C; Axelson H; Sandstedt B; Cserjesi P; Olson EN; Påhlman S
Lab Invest; 1999 Jan; 79(1):67-79. PubMed ID: 9952112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
